Flex Pharma, Inc. (47) | Business Finance (15)

Browse by Subcategory

Recent Contracts

Underwriting Agreement, March 4, 2021, between Salarius Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc., as representative of the several underwriters (Filed With SEC on March 8, 2021)
Form of Inducement Warrant (Filed With SEC on December 11, 2020)
Salarius Pharmaceuticals, Inc., 2015 Employee Stock Purchase Plan, as amended (Filed With SEC on June 19, 2020)
Registration Rights Agreement, dated October 24, 2019, between Salarius Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 28, 2019)
Asset Purchase Agreement dated July 23, 2019 by and among Salarius Pharmaceuticals, Inc., Flex Innovation Group LLC and Cliff-Cartwright Corporation (Filed With SEC on July 24, 2019)
Form of Inducement Warrant (Filed With SEC on December 11, 2020)
Underwriting Agreement, July 30, 2020, between Salarius Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc., as representative of the several underwriters (Filed With SEC on August 3, 2020)
Underwriting Agreement, dated February 7, 2020, between Salarius Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc., as representative of the several underwriters (Filed With SEC on February 12, 2020)
Common Stock Purchase Warrant dated February 11, 2020 (Filed With SEC on February 12, 2020)
Form of Underwriting Agreement (Filed With SEC on February 6, 2020)
Form of Common Stock Purchase Warrant (Filed With SEC on February 6, 2020)
Form of Preferred Stock Certificate of Registrant (Filed With SEC on February 6, 2020)
Form of Underwriting Agreement (Filed With SEC on January 28, 2020)
Form of Common Stock Purchase Warrant (Filed With SEC on January 28, 2020)
Common Stock Purchase Agreement, dated October 24, 2019 between Salarius Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 28, 2019)